17 February 2022
: Case report 
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)
Sara Al-Rasbi12ABEF, Juhaina Salim Al-Maqbali3ABEFG*, Rajaa Al-Farsi2BE, Moza Ali Al Shukaili4BE, Maryam H. Al-Riyami2EF, Zubaida Al Falahi1EF, Hatem Al Farhan12AG, Abdullah M. Al Alawi12AEFGDOI: 10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
Related articles
Coming soon...
In Press
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946476
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945837
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945952
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945718
Most Viewed Current Articles
21 Jun 2024 : Case report
82,268
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
48,844
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report 
23,077
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report 
21,943
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030